Yökastelu.net



Summary and
legal disclaimer
 
Evidence based medical reports

All contents on this site - www.yokastelu.net - is based on latest medical publications, judgement thereof and on available, evidence based medical reports. All main arguments are presented on a committee report, Nocturnal enuresis: A suggestion for a European treatment strategy. This article is published on the following journal: Acta Paediatrica 88:679-90, 1999.

In this referred review article seven outstanding opinion leaders did include the results of all major European scientific studies over the last 15 yrs. The writers concluded: the enuresis is the cause and not the result of a psychiatric disorder. It is of vital importance that a caring approach from the doctor and a positive family and patient attitude are created to enable successful treatment. This site exists to sustain that goal.
The first choice of treatment of nocturnal enuresis (MNE) should be the one most acceptable to the family.

The treatment options are: alarm (mechanical wake up devices), desmopressin and a combination therapy, where the two mentioned are used together. Desmopressin is the treatment of choice in children with MNE. There is also a place for desmopressin in children who have failed to respond to, or who have withdrawn from alarm therapy, or for whom alarm therapy is unacceptable.

All contents follow the rules and regulations described by finnish legal authorities, Lääkelaitos, on internet publications over medical issues.

Contents

The website - www.yokastelu.net - contains four parts:

The first part is a text based description of symptoms, causes of the symptoms and history of epidemiological causes of nocturnal enuresis. Treatment options are presented as they occur in medical, approved literature. Text based part contains a printer friendly version; ready to be printed out without illustrations.

The second part of the website summarises the contents with the help of illustrations.

The third part of the website consists of a dynamic website modified by the users; it contains interactive interviews, frequently asked questions and answers to them, and a database collected for the benefit of patients, their families and doctors treating this disorder. This part of the website is used to collect data from patients who have received a doctors prescription to use desmopressin. All information is collected in encrypted and secured data transmission transfer mode.

A special section of the segment is devoted to emphasise the safety behaviour in conjunction of desmopressin medical treatment. In special circumstances desmopressin treatment has had unwanted and unexpected consequences not related to the medicine itself but to the overload of water in patients receiving desmopressin therapy.

The fourth part of the website contains a cartoon type drawing to introduce a diary for personal follow up of the enuresis symptom, its treatment and success of the treatment chosen. This serves as a personal aid to follow up and as a report vehicle.

No warranty and no liability

Ferring Pharmaceuticals makes no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided on this website.

Same concerns any liability for the use of this site or any site linked to it. Ferring Pharmaceuticals may change this site at any time without notice but does not assume any responsibility of updating it continuously. All use of this site is at user's agreed own choice.

Neither Ferring Pharmaceuticals nor any other person or Dolphin Interactive Ltd involved in creating, producing or delivering this website or on any website linked to this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or other form of damage arising out of user's access, use or inability to use this site or any website linked to this site, or any errors or omissions in the content thereof.

No offer and no solicitation

The information provided on this website does not constitute an offer of or solicitation for the purchase or disposal of, trading or any transaction of Ferring Pharmaceuticals. Investors must not rely on this information for investment decisions.

Links

Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.

Copyright

The website www.yokastelu.net and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited. Request for permission to reproduce any information contained on this website should be addressed to Dolphin Interactive Ltd. The copyright is limited to Ferring Lääkkeet Finland. All software programming, the dynamic html code and database engines may not be used, copied, modified or transmitted without a written agreement of creators and Dolphin Interactive Ltd´s agreement and permission.

Etusivu   Sivukartta   Palaute



Ferring Lääkkeet Ferring Lääkkeet Oy, PL 23, 02241 Espoo. Puh. 0207 401 440. Fax 0207 401 449.
Summary and legal disclaimer.
Päivitetty 3.11.2008